Clinical Trials Logo

Clinical Trial Summary

This investigation aims to confirm the safety and effectiveness of Princess VOLUME PLUS Lidocaine in midface volume deficit augmentation and includes a long term safety followup.


Clinical Trial Description

This non-interventional study will evaluate subjects treated with Princess VOLUME PLUS Lidocaine for midface volume deficit augmentation. A touch-up treatment will be allowed, on discretion of the treating investigator, if the initial treatment didn't provide optimal correction. The effectiveness parameters will be evaluated based on a validated scale for midface volume deficit scale and confirmed by use of patient reported outcome questionnaires as well as based on photographs to be evaluated by an independent evaluator. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03532126
Study type Observational
Source Croma-Pharma GmbH
Contact
Status Completed
Phase
Start date March 28, 2018
Completion date June 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT04971876 - Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler N/A
Active, not recruiting NCT04132518 - Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency N/A
Active, not recruiting NCT04784299 - To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume N/A
Completed NCT03289052 - Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency N/A
Completed NCT03097783 - Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency N/A